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The incidence of hypertension is high in the elderly and is present in 2/3 of the patients older than 65 years. Prevalence can
reach 90% in patients older than 80 years. The presence of isolated systolic hypertension (ISH) is characteristic of this population.
However, the prevalence of hypertension by ambulatory blood pressure monitoring (ABPM) is not well known. In this study, we
analyzed the special characteristics of hypertension in this population, giving special emphasis on ABPM readings.
1.Introduction
The incidence of hypertension is high in the elderly, and
it is present in 2/3 of the patients older than 65 years [1].
Prevalence can reach 90% in patients older than 80 years
[2]. Systolic blood pressure (SBP) increases with age [3],
and the presence of isolated systolic hypertension (ISH) is
characteristic of this population. However, the prevalence
of hypertension diagnosed by ambulatory blood pressure
monitoring (ABPM) is not well known. The PROOF study
[4] carried out in French patients aged older than 65 years
showed that clinical blood pressure (CBP) was elevated in
58% of the patients, and 31% had diurnal SBP >135mmHg
by ambulatory monitoring. In this study, we analyzed the
special characteristics of hypertension in this population,
giving special emphasis on ABPM readings.
2. CharacteristicsofHypertensionintheElderly
Ageing results in a decline in the cardiac output and cardiac
frequency (beta-receptors-mediated response), as well as a
trend towards ventricular hypertrophy, reduction of the left
ventricular ﬁlling, renal plasma ﬂux and renin plasma, and
an increase in renal and peripheral resistances.
Ageing also produces an increase in arterial stiﬀness, a
reduction of the compliance, and an increase in the pulse
pressure; this, together with an increase in peripheral re-
sistances, leads to ISH. Several systems are involved in the
increase of peripheral resistances, such as reduction of beta-
2 receptors involved in vasodilation, or reduction in sodium
ions, potassium and calcium ions, renin-angiotensin system,
sympathetic nervous system, hormones, natriuretic factors,
and endothelial factors. All this can explain the frequency
of ISH, blood pressure (BP) variability, and the episodes
of associated orthostatic hypotension. Old subjects present
more frequently essential hypertension (except for renovas-
cular secondary hypertension) and more severe target organ
damage than the younger population. Hypertension aﬀects
subjects with a higher prevalence of ischemic heart disease,
myocardial infarction, diastolic dysfunction, a tendency to
arrhythmia and in general cerebral arteriosclerosis and
peripheral arterial disease. There are also present other
factors such as diabetes, and other concomitant diseases like
pulmonary disease, depression, neoplasia, and so forht that
should be considered when making diagnosis and treatment
decisions.
3.NormalityValues
Normality values of ABPM are based on several studies
[5]( Table 1) on adult populations older than 65 years,
despite that it is less represented by subjects aged 70–752 International Journal of Hypertension
Table 1: Blood pressure values in adults according to ABPM.
Optimal values Normal values High values
Wake cycle <130/80 <135/85 >140/90
Sleep cycle <115/65 <130/70 >135/75
years or older. Published reports of patients older than
65 years showed mean daytime BP values ranging from
128/77mmHg [6] to 140/78mmHg in a UK study (includ-
ing ambulatory and hospitalized patients), 134/81mmHg
in a healthy population [7, 8]i nG e r m a n y ,a n dv a l u e so f
138/82mmHg were found in patients aged 60–79 years and
147/83mmHg in patients older than 80 years [9]. These
values could be higher in diabetics or high vascular risk
patients.
Therefore, normality values must be carefully studied
in patients older than 80 years. It is not known yet the
beneﬁt of reducing clinical BP in this population group.
Previous studies like HYVET, demonstrated a reduction in
the mortality rate in 3.845 patients with SBP >160mmHg,
with the aim of reaching values of SBP <150mmHg, but
this study included patients with good physical and mental
conditions, without previous cardiovascular disease, and
only 7% of them were diabetics.
Bejan-Angoulvant et al. [10] carried out a meta-analysis
in patients older than 80 years and demonstrated that
intensive treatment reduced 35% of the risk of stroke, 50%
of the risk of heart failure, and 27% of cardiovascular events,
without diﬀerences in total mortality.
Evidences of reducing BP under 140/90mmHg in old
subjects has been recently discussed; however, any active
treatmenttrialversusplacebotherapyhasbeenabletoreduce
SBP under 140mmHg [11]. Therefore, there is no clinical
evidence showing which are the normal BP values in old
patients and even less by ABPM measurement.
4. IsolatedSystolic Hypertension
ABPM data of patients with ISH are mainly reported in the
SYST-EUR study [12], in patients older than 60 years with
baseline clinical systolic blood pressure (CBP) values of 160–
219mmHg and diastolic BP values lower than 95mmHg.
Patientswererandomizedandtreatedwithnitrendipine(10–
40mg/d) and the possible addition of enalapril (5–20mg/d)
according to BP values and/or hydrochlorothiazide (12,5–
25mg/d) and were compared to placebo. SBP was associated
with a poorer prognosis.
Clinical SBP of 160mmHg was correlated with a 24-
h SBP monitoring of 142mmHg, 145mmHg for daytime
BP, and 132mmHg for nighttime BP. Diﬀerences of the
SBP between clinical and ambulatory BP measurement were
higher in old subjects (Figure 1).
As t u d y[ 13] carried out in 578 patients aged older than
70 years demonstrated not only the predictive capacity of
ABPM with respect to cardiovascular morbidity but also the
capacity to diagnose hypertensive patients with normal BP
values at the doctor’s oﬃce.
Today, the US and European consensus for ABPM agrees
that ABPM measures are important in children and old
people, since CBP does not reﬂect accurately real BP values
in these population groups [14]. This is very important
to control antihypertensive therapy and establish the most
adequate treatment.
5. Pulse PressureandArterialDistensibility
Both conditions are more frequently found altered in older
ages. It is well known that pulse pressure (PP) is an
independent cardiovascular risk factor especially present in
old subjects [15, 16] as a result of a decline in left ventricular
ejection, arterial distensibility, and reﬂected wave velocity.
ABPM is a better estimate of PP than CBP. SYST-EUR
analyzed PP by ABPM in 808 patients.
In the placebo group, 24-h and nighttime PP was
predictive of total and cardiovascular mortality, stroke, and
cardiac events. Daytime PP was a predictor of cardiovascular
mortality, all cardiovascular events, and stroke. The hazard
rates for 10mmHg rise was from 1.25 to 1.68; however,
conventional measurement of pulse pressure was 1.35. No
signiﬁcant diﬀerences were found in the active treatment
group.
Staessen et al. [17] reported that PP estimated by ABPM
was a better predictor of events than that measured using
CBP in old people with ISH.
In the PIUMA study [18], ABPM values were observed
in 2010 untreated hypertensive patients. In this study 24-h
PP distribution into terciles was associated with an increase
in cardiovascular mortality of 1.19, 1.81, and 4.92 after
adjustment for other risk factors. It is suggested that 24-h PP
is a good predictor especially when values are higher than
53mmHg. Later, in a 3.8-year follow-up study [19] carried
out in patients older than 60 years, the highest SBP and PP
and lower DBP were correlated with mortality. A median
nighttime PP of 78mmHg of the 4th quartile showed a 4.4
times greater risk when compared with the ﬁrst quartile of
PP.
However, Masahiro et al., in a study carried out in
1542 Ohasama residents, found that the ambulatory arterial
stiﬀness index (AASI) and PP were reliable to measure
arterial stiﬀness and to predict vascular mortality, although
PP when adjusted for age and gender was less eﬃcient in
the prognostic value of vascular events of the ABMP or AASI
[20].
Arterial distensibility can be measured indirectly by
pulse wave velocity, which is altered with age. Asmar et al.
[21] found a good correlation between ABPM and arterial
distensibility; therefore, ABPM could provide indirectly a
reliable assessment of arterial distensibility.International Journal of Hypertension 3
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Figure 1: Patient aged 78 years with isolated systolic hypertension and riser pattern.
6.Nighttime SystolicBlood Pressure
Nighttime SBP is becoming more and more important,
as reported in the SYST-EUR study [12]o rH O P Es u b -
study [22] in which the eﬀect of nighttime administration
of ramipril produced a signiﬁcant fall (17/8mmHg) in
nighttime BP values, not appreciated in CBP measurement.
In an Anglo-Scandinavian cardiac outcomes trial substudy
(ASCOT) [23] carried out in patients with a mean age of
63 years, nighttime SBP was a predictor of vascular events.
ThedecreaseinnighttimeSBPwashigherintheamlodipine-
perindopril group than in the atenolol-thiazide group with-
out diﬀerences in the daytime BP values. The diﬀerences
found in the nighttime BP could explain the higher beneﬁt
obtained in the amlodipine-perindopril group. DUBLIN
study [24] analzed the relationship between CBP, ABPM,
and mortality in 1144 patients aged older than 65 years, and
found that nighttime SBP was the best correlated, with a risk
ratio estimation of 1.18 (1.11–1.25, P<0.001).
7. Hypotension
Orthostatic hypotension can occur at any age; however, it
is more frequent in the elderly. It is deﬁned as a decrease
in the SBP of at least 20mmHg or a decrease in the DBP
of 10mmHg in the orthostatic position 3 minutes after BP
measurement in the supine position [25]. It is generally
associated with dizziness, slight sweating, and sometimes
it is asymptomatic. ABPM is a better predictor of these
events than CBP [26]. Many of these events are related
to medication (diuretics and beta blockers), diabetes, or
disautonomy (baroreceptors) and are more frequently found
in the elderly.
Postprandial hypotension is more frequently found in
old subjects [27] and is deﬁned as a decrease in SBP of more
than 20mmHg up to 1 hour after eating, without alteration
of heart rate. Postprandial hypotension has been reported
as predictor of mortality in some studies [28, 29]. Figure 2
showstheABPMreadingsofanoldsubjectwithhypotension
episodes.
8. White-Coat Hypertension
Thewhite-coateﬀectoccurswhenCBPistemporaryelevated
in the clinical setting but not at home. This phenomenon
was described by Scipione Riva-Rocci in 1897, but it was
really studied in the clinical setting after the introduction of4 International Journal of Hypertension
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Figure 2: Patient of 79 years old with hypertension and diabetes. Combined therapy with 4 antihypertensive agents. Hypotensive episodes.
ABPM. Its prognostic signiﬁcance is not yet clear. In some
studies [30–32] mortality rate was 2 or 3 times higher, and
it was considered an independent factor for left ventricular
mass hypertrophy, increase of arteriosclerosis, or increase
in carotid intima-media. Other authors [33, 34] think that
white-coat hypertension (WCH) does not correlate with
organ damage or cardiovascular events. Age was found to
be an independent and common factor inﬂuencing WCH in
the multivariate analysis of diﬀerent studies [35–37]. WCH
clearly increases with age. In old patients with ISBP [38] the
eﬀectofSBPreached21mmHg.Theseauthorsreportedthat
the elevation of CSBP in untreated old patients is the main
factor to suspect white-coat eﬀect.
9. Masked Hypertension
Masked hypertension is deﬁned as a normal blood pressure
(BP) in the clinic or oﬃce (<140/90mmHg), but an elevated
BP out of the clinic (ambulatory daytime BP or home BP
>135/85mmHg) [39]. Its prevalence is not well known,
but it has been suggested to be about 10–20% of the
general population [40, 41]. It is well known that it is
associated with a more severe lesion of the target organ
[42–44] and cardiovascular events [13, 45]. It seems that
MH is not more frequent in old patients. Bobrie et al.
[46] in a study carried out in 4939 patients older than
65 years, reported a prevalence of MH of 9.4%, with CBP
<140/90mmHg for oﬃce BP and 135/85mmHg for home
BP. In fact, it has been suggested that masked hypertension
must be suspected in smoker young men, with unhealthy
lifestyle, high vascular risk, diabetics, presence of renal
disease with proteinuria, daytime hyperactivity, and patients
with transient hypertension [47].
10. CircadianBlood PressurePatterns
ABPM allows knowing BP absolute values and gives infor-
mation about circadian BP rhythm. According to these
patterns, patients are classiﬁed as dipper (a decrease of BP
at night >10%), nondipper (BP decrease <10%), extreme
dipper (BP decrease >20%), and riserpattern(an elevation of
BP at night). There are increasing evidences that nondipper
pattern is associated with a poorer cardiovascular prognosis
[48, 49], which has been reported by Staessen et al. [12]i n
old patients with ISH. Other authors reported that the non-
decrease of BP at night is related to the degree of concurrent
lesion of the target organ, severity of cardiovascular disease,
and alterations in sleep quality [50].
Patients with a lower decrease of BP at night due to
insomniadonotseemtopresentapoorervascularprognosis,
or, if so, it is not related to the nondipping pattern but
probably due to a higher value of nocturnal BP [51]. Sleep
qualityalterationsaremorefrequentintheelderly;therefore,
the circadian pattern in these patients must be carried out
more carefully. The 24-hour diary to record daily ABPM
is indispensable in these patients to adjust the sleep-wake
cycle.
A prevalence of 25–35% of the nondipping pattern was
observed in the general population. A Spanish study [52]
carried out in 42,947 patients showed a nondipping pattern
of 41%, which reached 53% in treated hypertensive patients.
This pattern can reach up to 60% in high-risk patients [53].
Itmustberememberedthatoldpatientspresenthigherlevels
of SBP and a higher vascular risk, target organ damage,
diabetes,renaldisease,orassociateddisease,allofthembeing
related to the nondipping pattern [52]. Generally, the loss of
the circadian pattern with a lower decrease of nocturnal BP
is associated with age, both in men [54]a n dv e ryo l dw o m e n
[7], and in centenarian patients [8, 55].
The morning elevation of BP is also important [42, 56].
Kario et al. [57] in a study carried out in old patients found a
clear correlation between lesions in the white substance and
the morning elevation of BP, independently of the absolute
values of BP.
Furtherstudiesareneededinordertodeterminewhether
morning elevation of BP is especially relevant in the old
population.International Journal of Hypertension 5
Table 2: Studies published on ABPM in subjects older than 65 years.
Study (year) No. of
patients Age range Time of followup Results
Lee et al. (1995) [8] 102 65–93 NA Normality values
Fotherby and Potter (1995) [7] 108 65–>80 NA Normotensive values of ABPM
Nondipping pattern
Sega et al. (1997) [6] 800 65–74 NA Population base. Normality values
Hoshide (2002) [67] 811 41 months ABPM was more useful than CB P
in extreme dipper and riser patterns
Wing (2002) [68] 713 65–83 N/A ABPM prevents overtreatment
O’Sullivan et al. (2003) [9] 156 78 NA SBP was associated with age
Nondipping pattern and age
Bj¨ orklund et al. (2004) [13] 872 (men) 70 9.5yrs Prognosis of cardiovascular risk
Burr et al. (2008) [24] 1144 72 6.7yrs ABPM as mortality predictor.
Nighttime SBP as best predictor
Ungar et al. (2009) [19] 805 72 3.8yrs SBP, PP with low DBP, and
mortality
Gosse et al. (2010) [4] 955 >65 N/A Population base. Prevalence of
hypertension
Andrade et al. (2010) [62] 106 83 30 months ABPM predicts cardiovascular
events. SBP loads
NA: not applicable.
Diurnal and nocturnal BP variability (deﬁned by quan-
tiﬁcation of SD of mean BP) is associated with an increased
cardiovascular risk, left ventricular mass, and progression of
carotid intima-media thickness [58, 59]. Mediavilla Garc´ ıa
et al. [60] reported a signiﬁcant relationship between BP
variability, age, and glomerular ﬁltration. In the PIUMA
study [61] cardiovascular morbidity was associated with
BP variability and age. In a SYST-EUR substudy of 744
old patients, which analzed BP variability in 24h, daytime,
and nighttime, nocturnal BP variability of 5mmHg was
associated with an increased risk of cardiovascular event of
80% with respect to the placebo group.
11.Blood PressureinVery OldSubjects
Although several studies have reported the relationship
between ABPM and cardiovascular risk in the elderly
(Table 2), few studies have been published on subjects older
than 80 years. Generally these studies [7, 9, 55] are carried
out in patient samples with a diﬀerent population base too
smalltoobtainvalidconclusions;however,inthispopulation
subset older than 80 years, SBP by ambulatory measurement
was higher than that of the subgroup of younger patients.
Andrade et al. [62] recently studied 126 patients with a mean
age of 83.8 years. The variables associated with the number
of cardiovascular events during followup were patients with
a clinical history of cerebrovascular event and higher diurnal
SBP values.
12. High Blood Pressureand Dementia
Dementia from all causes has a prevalence of about 8% of
the population over 65 years. Between 15 and 30% of these
cases are vascular. In the elderly, subcortical small vessel
disease is known to be associated with vascular dementia.
Mildcognitiveimpairment(MCI)isdescribedasatransition
phase between healthy cognitive aging and dementia.
This concept facilitated case identiﬁcation in early stage,
anditsprogressionmaybepreventablethroughmodiﬁcation
of vascular risk factors as hypertension.
The SYST-EUR study [12] showed that a decrease of
7mmHg in SBP and 3,2mmHg in DBP over 3,9 years
will reduce signiﬁcantly the incidence of dementia. In the
Women’s Health Initiative Memory Study (WHIMS, [63]),
the cognitive function of 7.149 women aged >65 years was
assessed using the modiﬁed minimental state examination.
During a follow-up period of 4,5 years, women with
hypertension appeared to be at greater risk of dementia or
MCI. Based on these studies, hypertension is associated with
the development of MCI and dementia.
ABPM has been shown to provide a better predictive
value for cardiovascular events than clinic BP. Recent studies
have shown that ambulatory BP variation is associated with
cognitive function. High nocturnal SBP level [64], Nondip-
per status [65], and exaggerated BP variability are suggested
to be signiﬁcant determinants of cognitive impairment. In
addition, 24-hour SBP has been shown to be a independent
factor for brain atrophy in the elderly [66]. So an strict BP
control, including nighttime, may have a neuroprotective
eﬀect and prevent the incidence of dementia. The recent
literature support that ABPM would help us in an earlier
diagnosis of MCI.
13. Conclusions
In conclusion, there are many reasons to recommend
ABPM in hypertensive old patients, such as ISBP, diﬀerences6 International Journal of Hypertension
between clinical and ambulatory BP, PP, magnitude of
the white-coat eﬀect, assessment of orthostatic hypotension
values and its relationship with the patient medication,
nighttime hypertension, mild cognitive impairment and BP
variability. These important variables demonstrate that just
the fact of being an aged patient is a suﬃc i e n tr e a s o nt op e r -
form ABPM. We support that the diagnosis of hypertension
by ABPM may have substantial clinical and epidemiological
implications.
Even so, further studies are needed to demonstrate the
importance of ABPM values in the study of the morbidity
and mortality in these patients.
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